Does Finerenone Reduce New-Onset Atrial Fibrillation in Cardio-Kidney-Metabolic Syndrome?
A pooled analysis of three finerenone trials found a modest reduction in new-onset atrial fibrillation/flutter across the cardio-kidney-metabolic spectrum. PICO summary and expert commentary.
